Daprodustat Gets FDA AdComm Nod for Adults With CKD on Dialysis Daprodustat Gets FDA AdComm Nod for Adults With CKD on Dialysis

For the first time, a HIF-PHI-class agent won backing from an FDA advisory committee for treating anemia, but the panel voted against daprodustat for adults with chronic kidney disease not on dialysis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news